FDA Inspection 1135556 — Sundar Jagannath, MD
The FDA completed an inspection of Sundar Jagannath, MD on January 15, 2021 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 15, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- New York, NY (United States)